Marker lesion experiments in bladder cancer--what have we learned?
Gofrit
Ofer N
ON
Department of Urology, Hadassah Hebrew University Hospital, Jerusalem, Israel. ogofrit@gmail.com
Zorn
Kevin C
KC
Shikanov
Sergey
S
Steinberg
Gary D
GD
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017115:Catheter Ablation; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000970:Antineoplastic Agents